This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Note on Biotech Business Development
Hamermesh, Richard G.; Higgins, Robert F.Case HBS-807032-EEntrepreneurshipTo maximize their effectiveness, color cases should be printed in color. Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious issues that arise in the implementation of licensing agreements. Includes color exhibits.Starting at €8.20
-
Oriflame S.A. (A)
Hawkins, David F.; Misztal, Karol; Beyersdorfer, DanielaCase HBS-111050-EAccounting and ControlA direct-selling cosmetics company involved in emerging markets exhibits significant foreign exchange risk exposure and profitability swings in the wake of the 2008 financial crisis. Students must review the company's use of derivative instruments and other hedging techniques to establish whether it pursues the right FX risk mitigation strategy.Starting at €8.20
-
Cynthia Fisher and the Rearing of ViaCell, Teaching Note
Hamermesh, Richard G.; Higgins, Robert F.; Seefeld, ErinTeaching Note HBS-808115-ETeaching Note for [806002].Starting at €0.00
-
U.S. Food and Drug Administration
Higgins, Robert F.; Hamermesh, Richard G.; Fuller, Virginia A.Case HBS-807050-ELeadership and People ManagementDescribes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.Starting at €8.20
-
Danone: Changing the Food System
Bell, David E.; Gabrieli, Federica; Beyersdorfer, DanielaCase HBS-520053-EMarketingEmmanuel Faber, Chairman and CEO of the food and beverage company Danone, believed that humankind had only ten years to bend the curve on climate change and restore the biodiversity that the global food and agricultural ecosystem was critically dependent on. Upon becoming CEO in 2014, he had built on Danone's long history of CSR-engagement to give a boost to the company's mission to bring health through food to as many people as possible. In Sept...Starting at €8.20
-
Computerized Provider Order Entry at Emory Healthcare
Hamermesh, Richard G.; McFarlan, F. Warren; Morgan, Michael; Keil, Mark; Katz, Andrew; LaBorde, DavidCase HBS-311061-EInformation TechnologiesThe Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardizatiStarting at €8.20
-
La Ribera Health Department (A)
Herzlinger, Regina E.; Moloney, Emer; Beyersdorfer, DanielaCase HBS-315006-EEconomicsWhat Business Model elements enabled La Ribera to achieve this level of value? How can it improve on its 1% profit margin and better align itself with the Six Factors? The hospital hired a consulting firm that presented four new options that could potentially increase returns. Which, if any, best fit with the ten elements of its Business Model? The B case (9-318-134) contains the d nouement for La Ribera.Starting at €8.20
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCase HBS-212051-EFinanceCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Starting at €8.20
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
The IASB at a Crossroads: The Future of International Financial Reporting Standards B
Ramanna, Karthik; Misztal, Karol; Beyersdorfer, DanielaCase HBS-113089-EAccounting and ControlSupplement for case 111084. In late 2012, IASB chair Hans Hoogervorst, just over a year into his term, must address several serious geopolitical challenges that can derail IFRS growth. The SEC has issued a report outlining why the U.S. should not adopt IFRS. Other major economies such as Japan and India begin to dither on IFRS as well. The E--the IASB's main backers--is embroiled in a debt crisis that divides it; Britain--the strongest voice for ...Starting at €8.20